Severe Henoch-Schönlein purpura induced by cytarabine

Annals of Pharmacotherapy

Volumn 43, Issue 4, 2009, Pages 792-793

  Aktas, Bora ^a   Topcuoglu, Pervin ^a   Kurt, Ozlem Kar ^b   Ensari, Arzu ^a   Demirer, Taner ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b Department of Chest Diseases   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; CILASTATIN PLUS IMIPENEM; CYTARABINE; GENTAMICIN; IDARUBICIN; LEVOFLOXACIN; METHYLPREDNISOLONE; PREDNISOLONE; SULPERAZON; TEICOPLANIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANAMNESIS; ANAPHYLACTOID PURPURA; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; HUMAN; HUMAN TISSUE; LETTER; MALE; PRIORITY JOURNAL; SKIN BIOPSY;

ADULT; CYTARABINE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; PURPURA, SCHOENLEIN-HENOCH; SEVERITY OF ILLNESS INDEX;

EID: 65749110114     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L608     Document Type: Letter

References (8)

1. Rostoker G. Schönlein-Henoch purpura in children and adults: diagnosis, pathophysiology and management. BioDrugs 2001;15:99-138. (Pubitemid 32336911)
2. Saulsbury FT. Henoch-Schönlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore) 1999;78:395-409.
3. Gedalia A. Henoch-Schonlein purpura. Curr Rheumatol Rep 2004;6:3195-3202
4. ten Holder SM, Joy MS, Falk RJ. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother 2002;36:130-147 DOI 10.1345/aph.1A124
5. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245
6. Ahmed I, Chen KR, Nakayama H, Gibson LE. Cytosine arabinoside-induced vasculitis. Mayo Clin Proc 1998;73:239-242 (Pubitemid 28113501)
7. Demirçay Z, Gürbüz O, Alpdogan TB, et al. Chemotherapy-induced acral erythema in leukemic patients: a report of 15 cases. Int J Dermatol 1997;36:593-598
8. Cetkovská P, Pizinger K, Cetkovský P. High-dose cytosine arabinoside-induced cutaneous reactions. J Eur Acad Dermatol Venereol 2002;16:481-485 (Pubitemid 35174342)